Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2025-12-25 @ 9:44 PM
NCT ID: NCT00392951
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00392951
Study Brief: Sirolimus for Autoimmune Disease of Blood Cells
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Sirolimus Treatment Sirolimus treatment sirolimus: Tablet or liquid; taken once or twice daily; dosage is based on establishing a serum trough of 5-15 ng/ml by high-performance liquid chromatography (initial loading dose of 3 mg/m2 then 2.5 mg/m2 with adjustment based on serum trough) None None 1 30 15 30 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Vasculitis SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Mucositis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Elevated triglycerides and cholesterol SYSTEMATIC_ASSESSMENT Cardiac disorders None View
Acne SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Sun sensitivity SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Gastro-esophageal reflux disease SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View